WPATH, USPATH, EPATH Statement in Response to Calls for Banning Evidence-Based Supportive Health Interventions for Transgender and Gender-Diverse Youth

 
From: "WPATH Accounts" <wpath@PROTECTED>
Subject: WPATH, USPATH, EPATH Statement in Response to Calls for Banning Evidence-Based Supportive Health Interventions for Transgender and Gender-Diverse Youth
Date: November 22nd 2019

 

Statement in Response to Calls for Banning Evidence-Based Supportive Health Interventions for Transgender and Gender-Diverse Youth

Diversity in gender expression and variations in gender identity represent normative developmental processes for children and adolescents and are not inherently pathological aspects of the human experience. They are also not uniformly indicative of a future gender transition. These facts are substantiated by many reputable professional associations representing thousands of pediatric providers. Clinical guidelines for youth experiencing an incongruence between their gender identity and sex assigned at birth have been published, are widely used nationally, and are based on the current evidence. These guidelines support the use of interventions for appropriately assessed minors. The following organizations have pediatric clinical guidelines and/or policy statements on these issues: American Academy of Child and Adolescent Psychiatry, American Academy of Pediatrics, American Psychological Association, and the Endocrine Society. In response to recent critiques of supportive health interventions for transgender and gender-diverse youth, the boards of directors of the World Professional Association for Transgender Health (WPATH), its US chapter (USPATH) and its Europe chapter (EPATH) have authorized the following statement.

The process of pursuing a gender transition is highly individualized based on the youth's situation, family concerns, and various other factors. Thus, there is no “one-size-fits-all” clinical intervention. However, in general, mental health and medical professionals conduct evaluations of each youth/family to ensure that interventions used to promote emotional and psychological wellness in these youth are appropriate and meet the young person’s specific mental health and medical needs. As a result, professionals with experience and training to understand adolescent development and family dynamics are poised to understand the underlying factors behind a specific clinical presentation. Professionals who are experienced working with youth and families can distinguish parents who may be cautious and concerned from parents who might be pushing for medical changes when their child is not ready for them. The best interests of the child are always paramount for any responsible licensed provider.

Some critics have claimed high rates of regret regarding irreversible treatments or procedures such as reconstructive surgeries, implying that children are forced to undergo treatments they may regret. There are no studies to support these claims. However, recent studies show only a very small percentage of people who undergo gender transition as adults (when irreversible procedures may be administered) regret doing so: roughly 1-3%, which is a small number compared with rates of regret reported for much more common procedures. Most people who have regrets do so because of a lack of support or acceptance from their family, social groups, work, or other organizations. Conversely, the benefits that these medically necessary interventions have for the overwhelming majority of youth whose identities are incongruent with their sex assigned at birth are well-documented. Providers who collaboratively assess youths' understanding of themselves, their gender identity, and their ability to make informed decisions regarding medical/surgical interventions (which are not offered prior to puberty, and never without the youth’s assent) play a very important role in minimizing future regret.  

Some critics have called 'gender care' "child abuse"; providing care for a transgender child or adolescent is a serious undertaking which respects the best interests of each individual child. Withdrawing care for all transgender youth or adults or threatening to criminalize conscientious healthcare providers who work with transgender patients or clients using evidence-based care is a clear abuse of administrative and legislative power. Legislation that opposes needed treatment is of grave concern as it sustains harmful misconceptions about transgender youth and adults, as well as gender transition processes in general, and also devalues medical protocols, thus driving more people to seek services from providers who are willing to ignore the validated protocols that encourage responsible care.

For more information about clinical support for gender-affirming care, see the following links:

From the American Academy of Child and Adolescent Psychiatry:

https://www.aacap.org/AACAP/Latest_News/AACAP_Statement_Responding_to_Efforts-to_ban_Evidence-Based_Care_for_Transgender_and_Gender_Diverse.aspx

https://www.aacap.org/AACAP/Policy_Statements/2018/Conversion_Therapy.aspx

https://www.aacap.org/AACAP/Policy_Statements/2009/Sexual_Orientation_Gender_Identity_and_Civil_Rights.aspx

https://www.jaacap.org/article/S0890-8567(12)00500-X/fulltext

From the Endocrine Society:

https://www.newswise.com/articles/endocrine-society-urges-policymakers-to-follow-science-on-transgender-health

And from the American Academy of Pediatrics:

https://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/AAP-Policy-Statement-Urges-Support-and-Care-of-Transgender-and-Gender-Diverse-Children-and-Adolescents.aspx

https://pediatrics.aappublications.org/content/142/4/e20182162

WPATH Board of Directors

USPATH Board of Directors

EPATH Board of Directors

President

Vin Tangpricha, MD, PhD

President

Erica Anderson, PhD

President

Guy T’Sjoen, MD

President-Elect

Walter Pierre Bouman, MD, PhD

President-Elect

Madeline Deutsch, MD, MPH

President-Elect

Joz Motmans, PhD, MA

Secretary

Randi Ettner, PhD

Secretary/Treasurer

Emilia Lombardi, PhD

Secretary/Treasurer

Annelou De Vries, MD, PhD

Treasurer

Baudewijntje Kreukels, PhD

Immediate Past-President

Gail Knudson, MD, MEd, FRCPC

BOARD OF DIRECTORS

Tamara Adrian, JD

Marci Bowers, MD

Tone Maria Hansen, MSN

Ren Massey, PhD

Asa Radix, MD, MPH

Loren Schechter, MD

Jaimie Veale, PhD

Immediate Past-President

Joshua Safer, MD, FACP

BOARD OF DIRECTORS

Dana (Thomas) Bevan, PhD

John Capozuca, PhD

Lisa Griffin, PhD

Johanna Olson-Kennedy, MD, MS

Asa Radix, MD, MPH

Student Representative

Nova Bradford, BA

BOARD OF DIRECTORS

Timo O. Nieder

Alessandra Fisher

Christina Richards

Griet De Cuypere

WPATH Liaison

Walter Pierre Bouman, MD, PhD

EPATH Representative

Walter Pierre Bouman, MD, PhD

USPATH Representative

Erica Anderson, PhD

GEI Representative (Ex-Officio)

Lin Fraser, EdD

Student Representative (Ex-Officio)

Penelope Strauss, BA, MPH

 

 

STAFF

Executive Director

Sue O’Sullivan

sue@PROTECTED

Executive Director of Global Education & Development

Donna Kelly

donna@PROTECTED

Deputy Executive Director

Blaine Vella

blaine@PROTECTED

 

  • This mailing list is a private mailing list. There may be additional steps in order to join, and the List Owner controls who may leave the mailing list.
  • This mailing list is announce-only.

WPATH Accounts

Privacy Policy:

We recognize the importance of protecting the privacy of all information provided by users of this website. The data we collect will only be used to provide information you receive as a standard member benefit. You can be assured that we will not sell or distribute to third parties any of the information that we collect through this website. As a resource for our members, we provide links to other sites. While we expect those sites share the same high standards and respect for privacy, we cannot be held responsible for the content or the privacy practices utilized by these other sites.

https://www.wpath.org/privacy